Pharmafile Logo

KCR expanding into the UK and Germany

Contract research organisation registers two new entities

Polish contract research organisation (CRO) KCR has plotted out its plans to expand in western Europe, registering new business entities in London and Berlin.

The UK and Germany are not the only markets it plans to set up shop in, with CEO Mike Jagielski confirming that France will be the next country KCR aims for.

“I am very excited seeing KCR strengthening its visibility across Western Europe,” he said. “Having our own entities registered in these countries will make our collaboration even stronger. It will also equip KCR with local law benefits and make our business cooperation easier.”

To date the CRO has operated in these markets by partnering with local firms but now says it wants to “bring the business closer to western European customers”.

The move will see Warsaw-based KCR, which already operates across 18 countries in Europe, as well as the US, reverse to some extent a direction of travel that has historically seen CROs look from the west to eastern Europe.

Article by Tom Meek
5th March 2014
From: Research
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links